These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11761949)

  • 1. [Descriptive epidemiology of intrahepatic cholangiocarcinoma].
    Tsukuma H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():25-32. PubMed ID: 11761949
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk factors of intrahepatic cholangiocarcinoma: a case-control study].
    Zhou HB; Xu QR; Wang H; Zhou DX; Wang H; Wang Q; Zhou SS; Tu QQ; Sun ZQ; Ai L; Wu MC; Hu HP
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):935-9. PubMed ID: 20038337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral cholangiocarcinoma and intrahepatic calculi.
    Okuda K
    J Gastroenterol Hepatol; 1999 Dec; 14(12):1141-3. PubMed ID: 10634148
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risk factors of cholangiocarcinoma].
    Yamada S; Shimada M; Morine Y
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():618-21. PubMed ID: 25857099
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholangiocarcinoma: descriptive epidemiology and risk factors.
    de Martel C; Plummer M; Franceschi S
    Gastroenterol Clin Biol; 2010 Mar; 34(3):173-80. PubMed ID: 20202771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights of topic "Etiology and epidemiology of cholangiocarcinoma".
    Murakami Y
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):299-300. PubMed ID: 24740851
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.
    Parkin DM; Ohshima H; Srivatanakul P; Vatanasapt V
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):537-44. PubMed ID: 8268770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology.
    Okuda K; Nakanuma Y; Miyazaki M
    J Gastroenterol Hepatol; 2002 Oct; 17(10):1049-55. PubMed ID: 12201863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases.
    Nakanuma Y; Xu J; Harada K; Sato Y; Sasaki M; Ikeda H; Kim J; Yu E
    Pathol Int; 2011 May; 61(5):298-305. PubMed ID: 21501296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of cholangiocarcinoma.
    Shaib Y; El-Serag HB
    Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for cholangiocarcinoma.
    Ben-Menachem T
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cholangiocarcinoma among printing workers].
    Kumagai S
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():827-31. PubMed ID: 25857144
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer genes and cholangiocarcinoma.
    Petmitr S
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():80-4. PubMed ID: 9656355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
    Welzel TM; Mellemkjaer L; Gloria G; Sakoda LC; Hsing AW; El Ghormli L; Olsen JH; McGlynn KA
    Int J Cancer; 2007 Feb; 120(3):638-41. PubMed ID: 17109384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic sphincterotomy and long-term risk of cholangiocarcinoma: a population-based follow-up study.
    Mortensen FV; Jepsen P; Tarone RE; Funch-Jensen P; Jensen LS; Sørensen HT
    J Natl Cancer Inst; 2008 May; 100(10):745-50. PubMed ID: 18477806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The retrospective analysis of HBV and HCV infection in cholangiocarcinoma].
    Zou SQ; Liu XF; Guo RX; Li CL; Zhou XS; Zhu XG; Huang ZQ
    Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):417-9. PubMed ID: 12895347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case-control study of risk factors in cholangiocarcinoma].
    Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opisthorchiasis, Helicobacter pylori infection, cholangiocarcinoma, and L-fucose: Interrelationship.
    Mungmunpuntipantip R; Wiwanitkit V
    J Cancer Res Ther; 2024 Jan; 20(1):502-503. PubMed ID: 38261443
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology of primary and secondary liver cancers].
    Jepsen P; Kissmeyer-Nielsen P
    Ugeskr Laeger; 2008 Apr; 170(16):1323-5. PubMed ID: 18433588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.